Company: SNWV
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-014141
Chunk: 93

Company: SANUWAVE Health, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 8
Chunk 93
---
 *9 3 Additional paid-in capital238,685 176,979 Accumulated deficit(251,421)(220,049)Accumulated other comprehensive loss10 (111)Total Stockholders’ Deficit(12,717)(43,178)Total Liabilities and Stockholders’ Deficit$30,119 $22,416 

* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.

The accompanying notes to consolidated financial statements are an integral part of these financial statements.

F-3

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

Years ended December 31, 2024 and 2023

(In thousands, except share and per share data)20242023Revenue$32,634 $20,398 Cost of revenues8,084 6,035 Gross Margin24,550 14,363    Operating Expenses:  General and administrative11,348 8,674 Selling and marketing6,323 4,898 Research and development673 579 Depreciation and amortization789 752 Total Operating Expenses19,133 14,903    Operating Income (Loss)5,417 (540)   Other Income (Expense)  Interest expense(12,423)(12,946)Interest expense, related party(1,214)(2,677)Change in fair value of derivative liabilities(31,413)(9,621)Gain on extinguishment of debt6,326 - Other expense(893)(19)Other income2,855 - Total Other Expense(36,762)(25,263)   Net Loss Before Income Taxes(31,345)(25,803)   Income tax expense27 4    Net Loss$(31,372)$(25,807)   Other Comprehensive Loss  Foreign currency translation adjustments121 (44)Total Comprehensive Loss$(31,251)$(25,851)Net Loss per share:Basic and Diluted *$(7.03)$(12.19)Weighted average shares outstanding:Basic and Diluted *4,462,8832,116,936

* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares